Nanjing Yinguang Pharmaceutical Technology Co., Ltd. was founded in April 2016 and is a contract research organization (CRO) dedicated to providing full-process professional services and solutions for clinical trials in the research and development of human health products. Yinguang Pharmaceutical is committed to providing customers with a series of high-quality, high-efficiency and cost-effective comprehensive new drug clinical development services, including clinical monitoring, third-party audit, SMO services, medical writing, data management, statistical analysis, pharmacovigilance, medical translation, training, and medical conference services, aiming to help customers reduce R&D risks, cut R&D costs, save valuable time in product R&D, and ultimately advance the marketization process of products. The company is headquartered in Mufu Innovation Town, Gulou District, Nanjing City, Jiangsu Province, and has permanent offices in Beijing, Shanghai, Shenyang, Guiyang, Wuxi, Wuhan, Nanning, Guangzhou (under preparation) and other places. As of now, it has about 100 employees, all with a bachelor's degree or above.
The professional team of Yinguang Pharmaceutical is composed of a group of rigorous, dedicated, enthusiastic and experienced managers. In line with the philosophy of "professionalism, integrity, collaboration and win-win", the whole team, with the combination of strength and experience, has built a scientific, standardized and refined operating model and service process, strictly implements international standard operating procedures (SOP) and quality management systems, and conducts refined management of project operations in accordance with relevant NMPA regulations and the requirements of ICH and FDA. The founder/chairman/general manager of the company, Dr. Li Zhengqi, has more than 30 years of professional work experience in pharmacy and 16 years of technical and organizational management experience in GSP/GLP/GCP on-site inspections at the Center for Food and Drug Inspection of the former State Food and Drug Administration; he is an expert reviewer of the CDE and a senior domestic expert in pharmaceutical regulations and clinical pharmacy, and has participated in the formulation and revision of more than 10 clinical trial management regulations and standards; his editor-in-chief work "Practical Guide to Bioequivalence Testing" filled the gap in systematic research on bioequivalence testing in China and has become an important reference and implementation tool in the industry.
Since its establishment, all employees of Yinguang Pharmaceutical have met challenges, withstood tests and worked hard, achieving rapid performance growth and remarkable achievements in market expansion and team building, and have excellently and超额 completed all development goals.
The business scale has grown rapidly. Since its founding in April 2016, starting from zero, the company achieved leapfrog development in operating revenue from the million-yuan level to the ten-million-yuan level and then to the hundred-million-yuan level during the three years from 2016 to 2018. In 2018, the contract amount was about 200 million yuan, and operating revenue exceeded 100 million yuan.
Customer and supplier resources have been continuously expanded. As of now, the company has provided clinical trial outsourcing services to more than 50 well-known domestic pharmaceutical enterprises, completed more than 80 clinical trial projects, more than 90 third-party audit projects and more than 80 SMO projects, etc., assisted more than 20 drug clinical research institutions across the country in completing the construction of Phase I wards, and established in-depth cooperative relations with more than 10 leading drug clinical trial institutions among them.
The operational management efficiency is at a leading level. Through the continuous optimization of the company's operating model and the continuous deepening of talent team building and institutional system construction, the company's operational management efficiency has been continuously improved. In 2018, the per capita output of Yinguang Pharmaceutical was about 1.26 million yuan, far higher than the industry average.
Talent team building has shown results. In 2018, adopting the principle of combining introduction and cultivation, the company strengthened organizational guarantees, resource guarantees and cultural guarantees, comprehensively enriched the talent team and improved employee quality. The number of employees grew to nearly 100, and the core management team remained stable.
The corporate brand has been further established. Although the company has been established for a short time, it has developed into a well-known CRO service provider in the industry and is currently one of the larger bioequivalence testing CRO service providers in the country. The corporate brand has been generally recognized by customers and all sectors of society and has gained a good reputation.
Social recognition has been continuously enhanced. With the continuous development and growth of Yinguang Pharmaceutical, the company has successively obtained qualifications and awards such as technology-based small and medium-sized enterprise, high-tech enterprise, and advanced unit in Nanjing's "Mass Entrepreneurship and Innovation" meritorious competition. The company's chairman, Dr. Li Zhengqi, has successively won honorary titles such as the "High-level Entrepreneurial Talent Introduction Program" of Gulou District and Nanjing City, the "Dual Innovation Talent" of Jiangsu Province, and the "Entrepreneurial Nanjing" Innovative Entrepreneur Cultivation Program.
What does Nanjing Yinguang Pharmaceutical Technology Co., Ltd. require? Who is Nanjing Yinguang Pharmaceutical Technology Co., Ltd. hiring? recruitment: 医疗卫生/美容保健类占比最多占48.8%,其次是销售类占36.6%. What education can get in at ? 本科占比最多占63.4%,其次是大专占25.6%. High education required at ? 硕士占8.5%. Work experience required at ? 1-3年占比最多占41.5%,其次是3-5年占34.1%. Where are the job locations at ? 南京占比最多占51.2%,其次是合肥占25.6%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows